Task: Answer the multiple-choice question.
Question: Which drug exhibits a 3.688\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
[a] COC(=O)c1ccc(Cl)c(NS(=O)(=O)c2ccc3c(c2)OCCO3)c1
[b] COc1ccc(/C=N/NC(=O)c2cccc(Br)c2)cc1Cn1nc(C)cc1C
Answer: b. COc1ccc(/C=N/NC(=O)c2cccc(Br)c2)cc1Cn1nc(C)cc1C
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
COc1ccc(/C=N/NC(=O)c2cccc(Br)c2)cc1Cn1nc(C)cc1C
COc1ccc(/C=N/NC(=O)c2cccc(Br)c2)cc1Cn1nc(C)cc1C
3-bromo-N-[(E)-[3-[(3,5-dimethylpyrazol-1-yl)methyl]-4-methoxyphenyl]methylideneamino]benzamide